Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double Blind, Randomized, Placebo-controlled Clinical Trial to Investigate the Safety and Effects of Oral Vitamin K2 Supplementation in COVID-19

NCT04770740 is registered in ClinicalTrials.gov with Canisius-Wilhelmina Hospital as lead sponsor.

NCT NCT04770740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04770740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double Blind, Randomized, Placebo-controlled Clinical Trial to Investigate the Safety and Effects of Oral Vitamin K2 Supplementation in COVID-19
Lead sponsor
Canisius-Wilhelmina Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2021
Completion date
March 1, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19